American Century Companies’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

American Century Companies’s Portfolio SCLN Stock Details SCLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-406,929	Closed	-$4.48M	–	1443
2017 Q2	$4.48M	Sell	406,929 -25,138	-6%	-$251K	﹤0.01%	882
2017 Q1	$4.23M	Buy	432,067 +3,549	+0.8%	+$35.4K	﹤0.01%	920
2016 Q4	$4.63M	Buy	428,518 +93,638	+28%	+$936K	0.01%	876
2016 Q3	$3.43M	Buy	334,880 +227,987	+213%	+$2.48M	﹤0.01%	973
2016 Q2	$1.4M	Buy	106,893 +64,564	+153%	+$846K	﹤0.01%	1087
2016 Q1	$466K	Buy	+42,329	New	+$376K	﹤0.01%	1225
2015 Q2	–	Sell	-60,857	Closed	-$539K	–	1480
2015 Q1	$539K	Sell	60,857 -10,452	-15%	-$83.3K	﹤0.01%	1231
2014 Q4	$625K	Buy	+71,309	New	+$577K	﹤0.01%	1254
2014 Q2	–	Sell	-91,560	Closed	-$417K	–	1552
2014 Q1	$417K	Buy	91,560 +711	+0.8%	+$3.43K	﹤0.01%	1364
2013 Q4	$458K	Hold	90,849	–	–	﹤0.01%	1354
2013 Q3	$461K	Buy	+90,849	New	+$506K	﹤0.01%	1360

Other funds holding SCLN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GLG Partners London, United Kingdom $2.14B AUM 21.14% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

American Century Companies's SCLN Position: Q3 2017 in Review

American Century Companies sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q3 2017, closing a stake of 406,929 shares — an estimated $4.48M sold.

American Century Companies first reported a position in SCLN in Q3 2013 and held it in 11 quarters. The position peaked at $4.63M in Q4 2016. 129 funds tracked by Wall St. Rank hold SCLN as of Q3 2017.

American Century Companies reported no remaining Sciclone Pharmaceuticals Inc position as of Q3 2017 after selling out during the quarter.
American Century Companies sold 406,929 Sciclone Pharmaceuticals Inc shares in Q3 2017, an estimated $4.48M.
American Century Companies first reported a position in Sciclone Pharmaceuticals Inc in Q3 2013 and held it in 11 quarters.
American Century Companies's Sciclone Pharmaceuticals Inc position peaked at $4.63M in Q4 2016.
129 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q3 2017.

Based on American Century Companies's 13F filing for Q3 2017, filed 1 Nov 2017.